GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial (Q40638190)
scientific article published on June 1999
Language:
Current Data About GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial
(P31) (Q13442814)
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P304) 291-297
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P478) 39
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P577) Tuesday, June 1, 1999
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P921) (Q42824440)

(P1433) (Q7758608)
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P1476) "GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial" (language: en)
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

(P2093) Simmons SJ
(P1545) 1
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Tjoa BA
(P1545) 2
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Rogers M
(P1545) 3
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Elgamal A
(P1545) 4
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Kenny GM
(P1545) 5
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Ragde H
(P1545) 6
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Troychak MJ
(P1545) 7
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Boynton AL
(P1545) 8
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

Murphy GP
(P1545) 9
(P248)
(P698) 10344219
(P813) Friday, September 22, 2017

other details
description scientific article published on June 1999

External Links
(P356) 10.1002/(SICI)1097-0045(19990601)39:4<291::AID-PROS10>3.0.CO;2-9
(P698) 10344219